Search clinical trials for: RP6530
Total 16 results
-
University Hospital, MontpellierTerminated
-
Hoffmann-La RocheCompletedNeoplasmsUnited States
-
Rhizen Pharmaceuticals SACompletedNon Hodgkin LymphomaUnited States, Australia
-
Rhizen Pharmaceuticals SACompletedLeukemia, Lymphocytic, Chronic, B-CellGeorgia, Bulgaria, Poland
-
Rhizen Pharmaceuticals SACompletedHematological MalignanciesUnited States, Georgia, Poland
-
Columbia UniversityTG Therapeutics, Inc.Terminated
-
Rhizen Pharmaceuticals SAIncozen Therapeutics Pvt LtdRecruitingTriple Negative Breast Cancer (TNBC)India
-
Rhizen Pharmaceuticals SACompletedLymphoma, T-Cell, Cutaneous | Lymphoma, T-Cell, PeripheralUnited States
-
Rhizen Pharmaceuticals SACompletedLymphoma, B-Cell | T-Cell LymphomaFrance, Italy
-
Rhizen Pharmaceuticals SATerminatedClassical Hodgkin LymphomaUnited States
-
Rhizen Pharmaceuticals SACompleted
-
Rhizen Pharmaceuticals SACompleted
-
Pfenex, IncCompleted
-
Heron TherapeuticsCompletedChemotherapy-induced Nausea and VomitingUnited States
-
Heron TherapeuticsCompletedUnspecified Adult Solid Tumor, Protocol Specific | Nausea and VomitingUnited States
-
National Cancer Institute (NCI)Active, not recruitingPRETEXT I Hepatoblastoma | PRETEXT II Hepatoblastoma | PRETEXT III Hepatoblastoma | PRETEXT IV HepatoblastomaUnited States, Canada, Puerto Rico, Australia, Japan, Brazil